Reuters logo
BRIEF-ABEONA ANNOUNCES TOP-LINE ONE YEAR DATA FROM ABO-102 MPS IIIA TRIAL
October 6, 2017 / 3:20 PM / 2 months ago

BRIEF-ABEONA ANNOUNCES TOP-LINE ONE YEAR DATA FROM ABO-102 MPS IIIA TRIAL

Oct 6 (Reuters) - Abeona Therapeutics Inc:

* ABEONA ANNOUNCES TOP-LINE ONE YEAR DATA FROM ABO-102 MPS IIIA TRIAL AT ARM’S CELL & GENE MEETING ON THE MESA

* ‍DEMONSTRATED DURABLE, SIGNIFICANT REDUCTION OF UNDERLYING DISEASE PATHOLOGY ACROSS MULTIPLE CLINICAL MEASURES IN COHORT 1 COMPARED TO CONTROLS​

* ‍“LOOK FORWARD TO REPORTING ADDITIONAL CLINICAL DATA FROM ABO-102 GLOBAL MPS IIIA TRIAL LATER THIS YEAR​” Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below